Suppr
超能文献

Bedside evaluation of thienopyridine antiplatelet therapy.

作者信息

Price Matthew J

机构信息

Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, CA, USA.

出版信息

Circulation. 2009 May 19;119(19):2625-32. doi: 10.1161/CIRCULATIONAHA.107.696732.

DOI:10.1161/CIRCULATIONAHA.107.696732

PMID:19451364

Abstract

摘要

相似文献

Bedside evaluation of thienopyridine antiplatelet therapy.

Circulation. 2009 May 19;119(19):2625-32. doi: 10.1161/CIRCULATIONAHA.107.696732.

Can we override clopidogrel resistance?

Circulation. 2009 Jun 2;119(21):2854-7. doi: 10.1161/CIRCULATIONAHA.108.857722.

Latest evidence in personalized antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Hosp Pract (1995). 2012 Apr;40(2):104-17. doi: 10.3810/hp.2012.04.976.

Prasugrel.

Expert Opin Investig Drugs. 2006 Dec;15(12):1627-33. doi: 10.1517/13543784.15.12.1627.

Another view on prasugrel.

Thromb Haemost. 2009 Jan;101(1):12-3.

[Antiplatelet therapy in coronary heart disease. Some problems and achivements].

Kardiologiia. 2010;50(6):4-21.

Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity.

Semin Thromb Hemost. 2005 Apr;31(2):184-94. doi: 10.1055/s-2005-869524.

Multiple electrode aggregometry and P2Y(12) antagonists.

Thromb Haemost. 2008 Jun;99(6):1127-9. doi: 10.1160/TH08-01-0054.

Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.

Circulation. 2009 May 19;119(19):2553-60. doi: 10.1161/CIRCULATIONAHA.109.851949. Epub 2009 May 4.

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel.

J Thromb Haemost. 2007 Dec;5(12):2429-36. doi: 10.1111/j.1538-7836.2007.02775.x. Epub 2007 Sep 26.

引用本文的文献

Differences in P2Y Reaction Units Between Prasugrel and Clopidogrel by Ischemic Cerebrovascular Disease Subtypes　- Subanalysis From ACUTE-PRAS.

Circ Rep. 2025 Jul 15;7(9):817-825. doi: 10.1253/circrep.CR-25-0077. eCollection 2025 Sep 10.

Platelets and diseases: signal transduction and advances in targeted therapy.

Signal Transduct Target Ther. 2025 May 16;10(1):159. doi: 10.1038/s41392-025-02198-8.

Exploring the relationship of platelet aggregation function with efficacy and safety outcomes following the administration of prasugrel and clopidogrel in patients with thrombotic stroke: a post hoc analysis of PRASTRO pooled studies.

J Thromb Thrombolysis. 2025 Apr;58(4):547-555. doi: 10.1007/s11239-025-03093-3. Epub 2025 Apr 14.

Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI.

J Geriatr Cardiol. 2024 Jan 28;21(1):90-103. doi: 10.26599/1671-5411.2024.01.004.

Platelets and Their Role in Hemostasis and Thrombosis-From Physiology to Pathophysiology and Therapeutic Implications.

Int J Mol Sci. 2022 Oct 23;23(21):12772. doi: 10.3390/ijms232112772.

Antiplatelet Therapy in End-stage Renal Disease Patients on Maintenance Dialysis: a State-of-the-art Review.

Cardiovasc Drugs Ther. 2023 Oct;37(5):975-987. doi: 10.1007/s10557-022-07366-4. Epub 2022 Jul 22.

Candidate Gene of NOS3, MMP3, AGT, and AGT1R and Pathway Analyses for Platelet Reactivity and Clinical Outcomes of Repeat Revascularization After First PCI in Chinese Patients.

Cardiovasc Drugs Ther. 2023 Jun;37(3):507-518. doi: 10.1007/s10557-021-07281-0. Epub 2021 Dec 3.

An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention.

Thromb J. 2021 Oct 19;19(1):73. doi: 10.1186/s12959-021-00323-5.

Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y Assay in Patients With Coronary Artery Disease.

Circ Rep. 2020 Dec 18;3(1):26-33. doi: 10.1253/circrep.CR-20-0124.

Impact of Routine Platelet Reactivity Testing with VerifyNow Assay on Antiplatelet Choice After Percutaneous Coronary Intervention.

Clin Pharmacol. 2020 Apr 16;12:35-41. doi: 10.2147/CPAA.S242675. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr超能文献

Bedside evaluation of thienopyridine antiplatelet therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译